共 48 条
- [31] BASELINE CHARACTERISTICS IN THE "IPACK-HD" STUDY (INHIBIT PROGRESSION OF CORONARY ARTERY CALCIFICATION WITH VITAMIN K IN HEMODIALYSIS PATIENTS): A PHASE 2, MULTI-CENTRE, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PILOT TRIALNEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1606 - 1606Babiolakis, CorinneZimmerman, DeborahMoist, LouiseDay, AndrewNormans, PatrickTurner, MandyGarland, JocelynAdams, MichaelBooth, SarahHeyland, DarenHolden, Rachel
- [32] International multi-centre randomised Phase II/III study of Capecitabine (Cap), bevacizumab (Bev) and mitomycin C (MMC) as first-line treatment for metastatic colorectal cancer (mCRC): Final safety analysis of the AGITG MAX trialJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Price, T. J.Gebski, V.van Hazel, G. A.Robinson, B. A.Broad, A.Ganju, V.Cunningham, D.Wilson, K.Tunney, V.Tebbutt, N. C.
- [33] Efficacy and safety of DBPR108 (prusogliptin) as an add-on to metformin therapy in patients with type 2 diabetes: A 24-week, multi-centre, randomized, double-blind, placebo-controlled, superiority, phase III clinical trialDIABETES OBESITY & METABOLISM, 2022, 24 (11): : 2232 - 2240Xu, JianpingLing, HongweiGeng, JianlinHuang, YanliXie, YingZheng, HuipingNiu, HuikunZhang, TianhaoYuan, JingXiao, Xinhua
- [34] Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III, multi-centre, double-masked randomised controlled trialTRIALS, 2016, 17Banerjee, Philip J.Cornelius, Victoria R.Phillips, RachelLo, Jessica W.Bunce, CateyKelly, JoannaMurphy, CarolineEdwards, Rhiannon TudorRobertson, Elizabeth L.Charteris, David G.
- [35] Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III, multi-centre, double-masked randomised controlled trialTrials, 17Philip J. BanerjeeVictoria R. CorneliusRachel PhillipsJessica W. LoCatey BunceJoanna KellyCaroline MurphyRhiannon Tudor EdwardsElizabeth L. RobertsonDavid G. Charteris
- [36] A multi-centre, participant-blinded, randomized, 3-year study to compare the efficacy of Virtual Surgical Planning (VSP) to Freehand Surgery (FHS) on bony union and quality of life outcomes for mandibular reconstruction with fibular and scapular free flaps: study protocol for a randomized phase II/III trialBMC CANCER, 2025, 25 (01)Tran, Khanh LinhTurkdogan, SenaDinur, Anat BahatMilner, Thomas D.Wang, EdwardNichols, AnthonyMacneil, DanielleMendez, AdrianJervis-Bardy, JakeDe Almeida, JohnYao, ChristopherGoldstein, DavidGilbert, RalphEskander, AntoineHiggins, KevinEnepekides, DannyGupta, MichaelZhang, HanAu, MichaelNguyen, SallyFels, SidneyHodgson, AntonyBrasher, PenelopeMitton, CraigSabiq, FarahnaFisher, CharlesYang, DavidWong, AngelaGarnis, CathiePoh, CatherineDurham, J. ScottPrisman, Eitan
- [37] A multi-institutional randomized phase III trial comparing anatomical segmentectomy and wedge resection for clinical stage IA non-small cell lung cancer in high-risk operable patients: Japan Clinical Oncology Group Study JCOG1909 (ANSWER study)JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (10) : 1209 - 1213Shimoyama, RyoTsutani, YasuhiroWakabayashi, MasashiKatayama, HiroshiFukuda, HaruhikoSuzuki, KenjiWatanabe, Shun-ichi
- [38] Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Coronary Heart Disease Complicating Chronic Heart Failure (Syndrome of Qi Deficiency with Blood Stasis): Study Protocol for a Randomized, Placebo-Controlled, Double-Blind and Multi-Centre Phase II Clinical TrialINTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 6177 - 6188He, XinglingJiang, YanhuiLi, SijingLiu, DonghuaLi, ZiruHan, XiaoweiZhang, XiaojiaoDong, XiaomingLiu, HaohuiHuang, JieWang, XiaojingLong, WenjieNi, ShihaoYang, ZhongqiYe, Taochun
- [39] SARS-CoV-2 vaccination and coronaviral disease 2019 in virologically suppressed people with HIV-1 previously on NNRTI-based antiretroviral regimen during the pandemic: The secondary longitudinal analysis of the SPRINT study, a multi-centre, randomised, active-controlled phase III trialJOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 307 - 307Lu, HongzhouWang, HuiHe, ShenghuaChen, ZhuChen, YaokaiWang, MinZhang, FujieWu, HaoCai, WeipingMa, PingZhao, QingxiaWei, HongxiaWan, WanFu, HeliangQin, Hong
- [40] Phase III, two arm, multi-centre, open label, parallel-group randomised designed clinical investigation of the use of a personalised early warning decision support system to predict and prevent acute exacerbations of chronic obstructive pulmonary disease: 'Predict & Prevent AECOPD' - study protocolBMJ OPEN, 2023, 13 (03):Kaur, DalbirMehta, Rajnikant L.Jarrett, HughJowett, SueGale, Nicola K.Turner, Alice M.Spiteri, MonicaPatel, Neil